Ancient herbs take on stroke: new trial tests dengzhan xixin and shengmai
NCT ID NCT07591883
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two traditional Chinese medicines, Dengzhan Xixin and Dengzhan Shengmai, in 358 adults who recently had an ischemic stroke. The goal is to see if these treatments improve recovery and reduce disability at 3 months. Researchers will also study how the medicines work using advanced testing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New anesthetic may keep blood pressure steadier during stroke clot removal
- Precision radiotherapy targets rare breast tumors by genetic fingerprint
- 20-Year study sheds light on rare breast tumor outcomes
- Eye reflexes may reveal ICU patient outcomes
- Tiny tumor clusters may predict colon cancer outcomes
- Could a simpler lymph node check replace major surgery for endometrial cancer?